Skip to main content
Download PDF

Blood type A associated with critical COVID-19 and death in a Swedish cohort—a critical comment

Critical Care volume 24, Article number: 547 (2020) Cite this article

I read with great interest the letter by Hultström et al. entitled “Blood type A associates with critical COVID-19 and death in a Swedish cohort” [1]. The authors report an association of blood group A with the risk of requiring critical care as well as with an increased risk of death within 30 days. The study is based on the blood group distribution from a Swedish critical care cohort (n = 64) compared to the blood type distribution in the population as a whole. It is stated that this latter study confirms earlier papers on blood type and COVID-19 severity such as a genome-wide association study by Ellinghaus et al. [2] and a clinical/serological study by Zietz and Tatonetti [3] both identifying blood group A as a risk factor for disease severity and death in COVID-19. Nevertheless, the letter gives rise to concerns.

First, the paper suffers from its control group, i.e., the general population. The findings do not allow for the conclusion that AB0 blood types influence the severity of symptoms since no comparison has been made between patients suffering from severe COVID-19 disease versus those only mildly affected (e.g., non-hospitalized) as a control group. Associations with blood type thus can also be expected if they affect one’s chance getting infected at all.

Secondly, the study by Zietz and Tatonetti, neither in its first nor in the second version of the preprint [3], does allow for the conclusion that on average blood group A coincides with a more severe course of COVID-19. According to the first version, the study “did not identify any significant relationships between blood group and intubation or death due to COVID-19.” As to the second version with more than two thousand individuals tested positive (COV+), the only significant AB0 blood group association was between blood group A and intubation but even with an opposite direction (odds ratio 0.762, 95% confidence interval [0.620–0.937], p = 0.0099).

Thirdly, another important study in the field [4] on 1289 COV+ individuals with a known blood type has not been cited. This study did not reveal an association between blood type and the risk of intubation or death.

In summary, the study by Hultström et al. should be interpreted with some caution.

Availability of data and materials

All data mentioned are in the public domain. No additional own data or unpublished 3rd party data were used.

Abbreviations

COV+:

Individuals tested positive for SARS-CoV-2

References

  1. Hultström M, Persson B, Eriksson O, Lipcsey M, Frithiof R, Nilsson B. Blood type A associates with critical COVID-19 and death in a Swedish cohort. Crit Care. 2020;24:496 https://doi.org/10.1186/s13054-020-03223-8.

    Article  Google Scholar 

  2. Ellinghaus D, Degenhardt F, Bujanda L, Buti M, Albillos A, Invernizzi P, Fernandez J, Prati D, Baselli G, Asselta R, et al. Genomewide association study of severe COVID-19 with respiratory failure. N Engl J Med. 2020; https://www.nejm.org/doi/pdf/10.1056/NEJMoa2020283?articleTools=true.

  3. Zietz M, Tatonetti NP. Testing the association between blood type and COVID-19 infection, intubation, and death. medRxiv. 2020; https://doi.org/10.1101/2020.04.08.20058073.

  4. Latz CA, DeCarlo C, Boitano L, Png CYM, Pater R, et al. Blood type and outcomes in patients with COVID-19. Ann Hematol. 2020;99:2113–8 https://doi.org/10.1007/s00277-020-04169-1.

    Article  CAS  Google Scholar 

Download references

Funding

No external funding.

Author information

Authors and Affiliations

  1. Institute of Medical Genetics, Medical Center, University of Rostock, D-18057, Rostock, Germany

    Joern Bullerdiek

  2. Human Genetics, University of Bremen, D-28359, Bremen, Germany

    Joern Bullerdiek

Authors
  1. Joern Bullerdiek
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

J.B. has written the letter. The author read and approved the final manuscript.

Corresponding author

Correspondence to Joern Bullerdiek.

Ethics declarations

Ethics approval and consent to participate

Does not apply.

Consent for publication

Does not apply.

Competing interests

The author declares that he has no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bullerdiek, J. Blood type A associated with critical COVID-19 and death in a Swedish cohort—a critical comment. Crit Care 24, 547 (2020). https://doi.org/10.1186/s13054-020-03264-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s13054-020-03264-z

Critical Care

ISSN: 1364-8535